This study describes a human bone marrow endothelial cell culture in which endothelial cells are organized into capillary tubes. These endothelial cells were positive for von Willebrand Factor, expressed CD34, CD31, and L-fucose residues, took up acetylated low-density lipoproteins, contained Weibel-Palade bodies, and were ensheathed in a basal lamina (which included laminin ␤1, EDaϩ and EDbϩ fibronectin, and collagen type iv). Pericytes expressing ␣-smooth muscle (␣-SM) actin were spatially associated with the capillary tubes and there was a highly significant correlation between the number of capillary tubes and pericytes. In this model, basal angiogenesis was found to be vascular endothelial growth factor (VEGF)-dependent, because neutralization of endogenous VEGF induced a dramatic regression in the number of tubes. However, the presence of ␣-SM actin-expressing pericytes in the linings of endothelial tubes partially prevented the VEGF-neutralized tube regression. We also observed that nitric oxide production contributed to basal angiogenesis and that upregulation of nitric oxide increased the number of tubes. Tube numbers also decreased when antibodies neutralizing the integrin ␣v␤5 were applied to the cultures. Moreover, addition of any of the hematopoietic cytokines, erythropoietin, stem cell factor, granulocytic colony stimulating factor, or granulomonocytic colony stimulating factor induced a highly significant increase in tube formation. When erythropoietin and granulocytic colony stimulating factor were added, this increase was larger than the maximum increase observed with VEGF. Thus, we have described an in vitro model for human bone marrow angiogenesis in which pericytes and basal lamina matrix were associated with endothelial cells and formed fully organized capillary tubes. In this model, cytokines known to regulate hematopoiesis also seemed to be mediators of angiogenesis. This culture system may therefore prove to be a valuable tool for the study of hematopoietic cytokines on angiogenesis. (Lab Invest 2000, 80:501-511).
T he marrow hematopoietic microenvironment comprises the non-hematopoietic elements found in marrow cords, ie, adipocytes, endosteal cells, and cells forming the vascular network (for review, see Charbord, 1999) . Vascular network cells are luminal endothelial cells or abluminal cells (pericapillary pericytes, parasinusal myoid cells, and vascular smooth muscle cells from the media of arterioles). Pericapillary pericytes and myoid cells are likely to play a central role in marrow homeostasis because they are associated with both endothelial and hematopoietic cells (Charbord et al, 1996; Galmiche et al, 1993) .
Because hematopoiesis takes place in mammals in an extravascular location, mature blood cells must cross the vascular wall. Both endothelial cells and abluminal cells contribute to the control of the release of hematopoietic cells (Lichtman, 1984) , and in pathologic conditions, the decrease in endothelial cell covering by adventitial reticular cells might favor the release of hematopoietic cells into the bloodstream (Wilson and Tavassoli, 1994) .
In vivo angiogenesis occurs in rare physiologic conditions such as menstruation and wound healing. On the contrary, it is observed in numerous pathologic states such as tumoral development and chronic inflammation (for review, see Folkman, 1996; Jackson et al, 1997) . Bone marrow angiogenesis has been reported in myelofibrosis (Reilly et al, 1985) and in acute lymphoblastic leukemia (Perez-Atayde et al, 1997) . Myelofibrosis (in case of agnogenic myeloid metaplasia or after polycythemia vera) is caused by mesenchymal cell proliferation secondary to the emergence of a neoplastic clone (Adamson et al, 1976; Jacobson et al, 1978) . The proliferation of the fibroblastic cells is partially caused by platelet-derived growth factor (PDGF), a well known angiogenic factor (Groopman, 1980) . Endothelial cells also proliferate in this disease (Reilly et al, 1985) ; this proliferation might also be induced by PDGF (Ishikawa et al, 1989) . In acute lymphoblastic leukemia, the bone marrow vascular network density and basic fibroblast growth factor (bFGF) levels in urine are significantly increased.
The involvement of vascular endothelial growth factor (VEGF) in acute lymphoblastic leukemia also seems likely because leukemic cells synthesize and release this angiogenic factor (Fiedler et al, 1997) .
Increased marrow angiogenesis is associated with increased bone marrow blood flow (Van Dyke et al, 1970) . This might be caused by the secretion of hematopoietic cytokines because administration of granulocytic colony stimulating factor (G-CSF) or erythropoietin (EPO) induces an increase in marrow blood flow in experimental animals (Iversen et al, 1992) . These data lead to the conclusion that, under specific pathological conditions, marrow endothelial cells might shift from a resting phenotype to an angiogenic phenotype. This is probably secondary to the growth of neoplastic or mesenchymal cells.
In this study, we describe an in vitro model of angiogenesis where endothelial cells form capillary tubes comprising basal lamina and surrounding pericytes. Basal angiogenesis is dependent on the presence of VEGF and is strongly upregulated by growth factors involved in the modulation of hematopoiesis. These data further suggest a potential link between marrow angiogenesis and hematopoiesis via common cytokine regulators produced by stromal cells.
Results

Culture Initiation and Maintenance
Thirty-six hours after the selected cells were plated, adherent cells were observed forming foci of 5 to 12 cells. The plot of foci number versus the number of cells seeded was linear (13 cultures analyzed; r 2 Ͼ 0.99). At high concentrations of plated cells, foci were too numerous to precisely count. At lower concentrations of plated cells, we found an average of one colony per 8000 cells. Adherent cells were spindleshaped, had dark cytoplasm, and their nucleus contained two or three nucleoli. These cells took up dil-acetylated-low density lipoproteins.
After 72 hours of culture, the foci also contained starry cells. These cells were widespread and had clear cytoplasm. The cultures were confluent after one to two weeks and consisted of a monolayer of elongated cells. Many of these cells were linearly arrayed, forming tubes.
After reaching confluence, the cultures were treated with trypsin. The resulting single cell suspension was cultured again in the same medium. After a few days, tube formation was observed again. Such cultures could be maintained for up to five passages and sixty days with persistent tube formation throughout the culture period.
Endothelial Cells are Organized in Tubes
Cells forming tubes were identified as endothelial cells. Their cytoplasm contained a granular material which was immunoreactive to an antibody to von Willebrand Factor (Fig. 1) , and similar, but spatially distinct, labeling was observed after incubation with acetylated low-density lipoproteins. Such endothelial cells always seemed to be organized in tubes; we never observed these immunoreactive cells forming cobblestone areas. The endothelial cell membrane was generally smooth, closely apposed, without any long finger-like processes, expressed CD31 and CD34 antigens, and bore ␣-L fucose residues which bound Ulex europaeus agglutinin-1 (Fig. 2) . The cells also expressed ␣v␤3 integrins and Intercellular Cell Adhesion Molecule-2, but not Intercellular Cell Adhesion Molecule-1 or Vascular Cell Adhesion Molecule.
At the first culture passage, we measured the number of von Willebrand factor-immunoreactive tubes per square centimeter. The number of tubes ranged from 20 to more than 600 per square centimeter. For Organization of endothelial cells. a, b, and c show different levels of tube development after labeling with a TRITC-conjugated antibody to von Willebrand Factor (vWF), corresponding to passage 1 (a, 21 days in culture), passage 2 (b, 30 days in culture), and passage 3 (c, 49 days in culture). At passage 1 (a), the few endothelial cells observed are already aligned in a tubular configuration. At passage 2 (b), five branching tubes form a network. At passage 3 (c) the network is dense and anastomosing. At each passage, the layers were trypsinized and the resulting cell suspension was cultured. The generation of the network resulted, therefore, from the growth of endothelial cells. Scale bar ϭ 10 m.
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54 cultures, the mean tube number was 167 Ϯ 37. Endothelial cells were associated with extracellular matrix material: EDaϩ and EDbϩ fibronectins (Fig. 3) , collagen I, and the basal lamina proteins, ␤1 laminin and collagen iv (Fig. 2) .
Ultrastructural studies confirmed the endothelial nature of the cells, because characteristic cigar-shaped Weibel-Palade bodies were observed. Ultrastructural studies also confirmed the tube formation (Fig. 4) . Lumens were either filled or not filled with cellular debris, and they were limited by two or three endothelial cells with apposed membranes forming close junctions. A basement membrane was usually observed on the non-luminal side of the endothelial cells.
Tubes are Surrounded by Pericytes Amidst Mesenchymal Stromal Cells
Stromal cells, clearly not endothelial by any of the characteristics mentioned above, were observed among the tube-forming endothelial cells. These cells were 1B10 immunoreactive, and expressed prolyl-5- hydroxylase and vimentin, confirming their mesenchymal nature. The cells closest to the tubes, that were dendritic, were immunoreactive for membrane chondroitin sulfate proteoglycans, and expressed ␣-SM actin in thin and tortuous microfilaments, were characterized as pericytes (Fig. 5 ).
There was a significant correlation (54 cultures analyzed; r 2 Ͼ 0.38; p Ͻ 0.001) between the number of tubes observed in a culture and the number of ␣-SM actin-expressing pericytes. Therefore, tubes and pericytes developed in parallel. It was observed that sprouting cells were either endothelial cells or pericytes, because they expressed either L-fucose residues or ␣-SM actin. This suggested that pericytes were instrumental in endothelial cell organization.
Key Molecules Involved in Basal Angiogenesis
The culture conditions to generate capillary tubeforming endothelial cells required coating the culture flasks with type I collagen and plasma fibronectin. The growth media required the addition of low amounts of fetal calf serum (2%) to E-Stim medium that of Endothelial Cell Growth Supplement (a mixture of fibroblast growth factors), and of heparin . However, tubes were also observed, although in decreased numbers, when cells were grown in M199 with 10% fetal bovine serum, or when flasks were not coated with collagen I or fibronectin.
Because these are the minimum requirements for tube formation, we asked two questions: 1) whether the addition of supplementary cytokines or other mediators would improve tube formation, and 2) whether we could identify key factors known to be involved in angiogenesis. To answer these questions, we either added or immunoneutralized factors that have been shown to modulate angiogenesis in other models.
Blocking either tissue-type (tPA) or urokinase-type (uPA) plasminogen activators with specific neutralizing antibodies resulted in a mean 20% decrease in tube formation. These results, however, were not significant at the p Ͻ 0.05 level (Fig. 6) .
The maximal effect of ␣v␤3 integrin immunoneutralization was found with application of 10 g/ml of antibody. This resulted in a small (approximately 10%) and not significant decrease in tube number compared with controls ( Fig. 6 ). In contrast, immunoneutralization of ␣v␤5 integrin with 10 g/ml of antibody significantly ( p Ͻ 0.01) decreased capillary-tube formation by 26 Ϯ 7%.
The addition of 1 to 10 ng/ml of recombinant human transforming growth factor beta (TGF␤)-1 (Fig. 7) , or the addition of 10 g/ml of anti-TGF␤ neutralizing antibody (Fig. 6 ) did not modify tube formation. When 1 ng/ml of bFGF was added (Fig. 7) , tube development was significantly reduced, to 87 Ϯ 10% of control levels ( p Ͻ 0.05), whereas the addition of 5 g/ml of anti-bFGF neutralizing antibody was without effect (Fig. 6 ). PDGF-BB and VEGF 165 had comparable angiogenic properties; 1 ng/ml of PDGF-BB induced an
Figure 6.
Effect of different mediators on basal angiogenesis. Tubes were counted after labeling, as described for Figure 6 . The maximal effect is shown for bFGF (1 ng/ml), TGF␤ (1 ng/ml), PDGF-BB (1 ng/ml), VEGF (1 ng/ml), hydroxyguanidine sulfate (NO donor; 10 M), and CoCl 2 (Hypoxia mimetic; 10 M). Pelletier et al increase in tube number by 47 Ϯ 25% ( p Ͻ 0.01), and 1 ng/ml of VEGF 165 induced an increase in tube number by 78 Ϯ 46% ( p Ͻ 0.01). We could not procure PDGF antibodies able to neutralize endogenous PDGF activity. Neutralization of VEGF in the culture medium dramatically reduced tube formation (Fig. 6) ; the number of tubes decreased to values as low as 32 Ϯ 9% of controls with 0.3 g/ml of VEGF antibody ( p Ͻ 0.01). Moreover, the neutralization of VEGF significantly decreased ( p Ͻ 0.05) the number of tubes with ␣-SM-expressing pericytes by 30 Ϯ 23%, and decreased the number of tubes without pericytes ( p Ͻ 0.01) by 59 Ϯ 4%. As a result, the proportion of tubes associated with ␣-SM-expressing cells significantly ( p Ͻ 0.01) increased from 26 Ϯ 6% to 41 Ϯ 6% after VEGF neutralization.
The diffusible gas nitric oxide (NO) has been shown to be involved in several aspects of vascular physiology, particularly in vascular network growth (Gooch et al, 1997) . In the presence of a NO stabilizer, hydroxyguanidine sulfate, angiogenesis was significantly ( p Ͻ 0.01) stimulated by 31 Ϯ 27% (Fig. 7) . The inhibition of NO production by endothelial cell NO synthase, through the addition of 1 mM of L-NAME (Fig. 6) to the culture medium, resulted in a significant ( p Ͻ 0.01) decrease in tube number by 14 Ϯ 17%.
The addition of 10 M CoCl 2 , which mimics some aspects of hypoxia (Ma et al, 1998) , induced a significant ( p Ͻ 0.01) increase in tube number, 46 Ϯ 25% (Fig. 7) .
Hematopoietic Cytokines Induce Major Increases in Tube Numbers
Because the formation of capillary tubes was associated with the stromal cells known to produce hematopoietic cytokines, and because of the known effect of some of these growth factors on marrow blood flow (Iversen et al, 1992; , we examined whether some of these cytokines were also able to modulate angiogenesis (Fig. 8) .
Stem Cell Factor (SCF) significantly increased ( p Ͻ 0.01) tube formation by 27 Ϯ 16% at 0.1 ng/ml (Fig. 8) .
Higher concentrations resulted in lower stimulation. Both G-CSF and granulomonocytic colony stimulating factor (GM-CSF) at 10 ng/ml increased tube development, by 65 Ϯ 27% ( p Ͻ 0.01) and 42 Ϯ 25% ( p Ͻ 0.01), respectively (Fig. 8) . This angiogenic effect was larger for higher doses (198 Ϯ 37% and 159 Ϯ 29% at 100 ng/ml, for G-CSF and GM-CSF, respectively). The addition of 1 U/ml of EPO to cultures induced a 52 Ϯ 30% ( p Ͻ 0.01) increase in tube number (Fig. 8) and 10 U/ml of EPO induced a doubling in the number of tubes (203 Ϯ 42%; p Ͻ 0.01).
No synergy or additive effect was found between SCF and the other three cytokines. The addition of up to 10 g/ml of neutralizing antibodies to G-CSF or GM-CSF did not decrease tube numbers.
Discussion
We have generated a culture system of human bone marrow cells which includes two major elements of the hematopoietic microenvironment, endothelial cells organized into tubes and surrounding pericytes. The appearance of foci at the onset of the culture, the linear relationship between the foci and the plated cells (one colony per 8000 endothelial cells), and the reproducible reappearance of endothelial cells with tube-forming capacity after each passage, argue for the existence of a subpopulation of bone marrow angioblasts. Circulating angiogenic precursors of endothelial cells contribute to angiogenesis after damage secondary to ischemia in mice and dogs (Asahara Neutralization of mediators. Tubes were counted after labeling with anti-vWF; numbers are expressed as the percentage of the values found in the control conditions (in the absence of any added mediators except for those regarded as the minimum requirements, see methods). The maximal effect is shown for 5 g/ml of anti-bFGF-, 10 g/ml of anti-TGF␤-, 0.3 g/ml of anti-VEGF-, 1 g/ml of anti-uPA-, 10 g/ml of anti-tPA-, 10 g/ml of anti-␣v␤5-and 10 g/ml of anti-␣v␤3-neutralizing antibodies, and for 1 mM L-NAME (NOS inhibitor).
Figure 8.
Effect of hematopoietic cytokines. Tubes were counted after labeling, as described for fig 6. Effect on tube development of 0.1 ng/ml of SCF, 10 ng/ml of GM-CSF, 1 U/ml of EPO, and 10 ng/ml of G-CSF. The maximal effect is presented for SCF and GM-CSF. For EPO and G-CSF, even higher stimulation was observed for cytokine concentration (200% of control value for 10 U/ml and 100 ng/ml, respectively). Shi et al, 1998) . In dogs, it has been suggested that the angioblasts were of marrow origin. Further studies should indicate whether the angioblasts in our culture system are also able to circulate.
Role of Hematopoietic Cytokines
Most models of in vitro angiogenesis are cultures of endothelial cells from different origins plated on extracellular matrix-coated surfaces or in an extracellular matrix protein gel (Baatout, 1997; Kubota et al, 1988; Montesano and Orci, 1987; Montesano et al, 1985) . In these models, despite the presence of extracellular matrix molecules, the onset of angiogenesis usually requires stimulation by growth factors and/or phorbol esters. However, tube formation is consistently and reproducibly observed in our system. Because our culture requirements are not fundamentally different from those used in other systems, consistent tube formation is probably linked to the simultaneous presence of mesenchymal cells. The ability of these endothelial cells to organize themselves even when using another culture medium (M199 with 10% fetal bovine serum), without any matrix, or when the matrix composition is modified (gelatin, collagen I or fibronectin alone) is in agreement with this hypothesis. The colocalization of pericytes (a subpopulation of mesenchymal cells) with endothelial tubes; the highly significant correlation between the number of tubes and the number of ␣SM actin-expressing pericytes; and the ability of both pericytes and endothelial cells to give rise to sprouts at the tips of the tubes all further reinforce the hypothesis of an interaction between the two cell populations. Moreover, in maturing blood vessels, endothelial cells recruit periendothelial mesenchymal cells that differentiate either into smooth muscle cells or into pericytes expressing ␣SM actin. Mesenchymal cells, and more specifically, pericytes, may be involved at the different stages of angiogenesis: endothelial cell proliferation, organization into tubes, and tube stabilization (for review, see Beck and D'Amore, 1997; Hirschi and D'Amore, 1997) . In our system, a reciprocal relationship between mesenchymal cells and endothelial cells seems likely, with endothelial cells being able to induce both ␣SM actin gene expression and pericyte generation from mesenchymal cells.
Angiogenesis is a complex process which involves basal lamina formation and remodeling, the presence of cell adhesion molecules, different sets of cytokines, and tone modulators (Beck and D'Amore, 1997) . We tried to determine some of the key factors involved in our system. Extracellular matrix plays a double role in angiogenesis: it is a material that has to be remodeled and built up during cell migration and organization, but it is also an informative support material that is involved in the balance between the angiogenic and quiescent states (Ingber, 1991) . In our system, the basal lamina was made of collagen iv, laminin ␤1, and EDaϩ and EDbϩ fibronectin, an expected composition for vascular tubes (Castellani et al, 1995; Paulsson, 1992) . Alternative splicing generates EDaϩ and EDbϩ fibronectin isoforms. The isoform containing the EDb sequence is regarded as oncofetal because it is undetectable in normal adult tissues, but is expressed in fetal and tumor tissues. Moreover, this production is restricted to new vessels, and thus is a marker for angiogenesis (Castellani et al, 1995) . This study did not provide evidence for basal membrane remodeling because treatment of cultures with antibodies directed against either uPA or tPA induced only a 15% (not significant) decrease in the formation of capillary tubes. In this respect, our system differs from that of other human microvascular endothelial cells where tPA activity has been shown to be required for growth factor-induced tube formation (Sato et al, 1993) . In our system, whether proteolytic activity is not absolutely required for tube formation, or whether matrix metalloproteases contribute primarily to this activity has not been determined.
The integrins are key factors of angiogenesis (for review, see Beauvais-Jouneau and Thiery, 1997). Brooks et al have shown that ␣ v ␤ 3 is restrictively expressed by angiogenic endothelial cells and that its blockade using neutralizing antibodies inhibited bFGF-induced angiogenesis without harming preexisting vessels (Brooks et al, 1994; . However, ␣ v ␤ 3 blocking had no effect on VEGF-induced angiogenesis (Friedlander et al, 1995) , indicating ␣ v ␤ 3 -independent, but ␣ v ␤ 5 -dependent, pathways for vessel development. In our system, although ␣ v ␤ 3 was expressed by endothelial cells, the blockade of this pathway did not impair tube formation, in contrast to ␣ v ␤ 5 blockade, which induced a significant 16% decrease. These results suggest that VEGF, not bFGF, is crucial in our culture conditions. The first well characterized angiogenic factor was bFGF (for review, see Bussolino et al, 1996) . In our model, the immunoneutralization of bFGF had no consequence, whereas the addition of bFGF (in addition to Endothelial Cell Growth Supplement) caused a slight but significant decrease in tube number. Because bFGF is a potent growth factor for marrow stromal cells (Sensebe et al, 1995) , it might have favored the growth of stromal cells more than endothelial cells.
Since it was described in 1989, VEGF has proven to be the most potent angiogenic factor. In our model, VEGF plays a key role, because addition of 1 ng/ml of VEGF significantly increased the number of capillary tubes by 78%, and, conversely, VEGF neutralization reduced the number of capillary tubes to values lower than before antibody treatment. These data strongly suggest that VEGF is a survival factor for angiogenic vessels from adult marrow, as observed for endothelial cells during hypoxic or tumoral development (Aiello et al, 1995; Benjamin and Keshet, 1997) . As observed in other systems, VEGF might prevent the apoptosis of marrow endothelial cells committed to angiogenic process (Alon et al, 1995) . We also observed that, although the total tube number decreased in the presence of anti-VEGF, the proportion of pericyteassociated tubes significantly increased, from 26% to 43%, indicating that the decrease in tubes was mainly due to a selective loss of tubes devoid of pericytes. Thus, our data add further in vitro evidence that immature tubes present a greater sensitivity to VEGF withdrawal (Benjamin et al, 1999) .
The major regulator of VEGF synthesis and release is hypoxia (Shweiki et al, 1992) . We found indirect evidence that human bone marrow endothelial cells respond to ischemia, because addition of CoCl 2, which mimics hypoxia (Ma et al, 1998) , actually increased the tube number by more than 40%.
VEGF was first described as a vascular permeability factor because it induces significant vessel leakage (Senger et al, 1983) . Endothelium Derived Releasing Factor, a central vasodilator identified as diffusible NO, also modifies the permeability of vessels (Palmer et al, 1987) . In our system, the NO stabilizer, hydroxyguanidine sulfate, significantly increased the number of capillary tubes, by 30%, whereas inhibition of NO production by L-NAME significantly reduced this number, by 15%. Whether or not NO contribution to human marrow angiogenesis is controlled by VEGF, as suggested in other systems (Morbidelli et al, 1996) , has not been addressed.
We conclude that VEGF seems to play a critical role for in vitro human bone marrow angiogenesis. Stromal mesenchymal cells synthesize VEGF and probably also release this growth factor (Sensebe et al, 1997a) . Hypoxia might increase the VEGF release, and VEGF is likely to act in concert with NO via the ␣ v ␤ 5 integrin pathway.
PDGF has a dual potential because it is involved in abluminal cell recruitment and is also a microvascular endothelial cell mitogen (Beitz et al, 1991 ). In our model, addition of PDGF-BB induced a significant increase in the number of capillary tubes. PDGF-BB might increase the recruitment of pericytes from stromal mesenchymal cells and might also be a mitogen for endothelial cells. In the absence of PDGF-BB neutralizing antibody, we could not assess whether PDGF-BB plays an active role under basal conditions of culture.
TGF␤1, another factor involved in angiogenesis (Beck and D'Amore, 1997) , is produced when endothelial cells interact with mural cells (Antonelli-Orlidge et al, 1989; Orlidge and D'Amore, 1987; Sato and Rifkin, 1989) . In our system neither addition nor neutralization of TGF␤ affected tube formation. However, the differentiation from mesenchymal cells to pericytes in the immediate vicinity of endothelial cells forming tubes indicates the relevance of cell to cell contact for maturation. Although TGF␤1 is probably critical for this maturation step (Beck and D'Amore, 1997) , it is possible that we were unable to neutralize the 0.17 ng/ml of active TGF␤1 provided by the serum.
The hematopoietic cytokines G-CSF, GM-CSF, and EPO have been proven to be growth factors for human umbilical and rat aortic macrovascular endothelial cells, and been proven to play a major role in regulating blood supply to bone marrow and hence in the release of mature blood cells (Anagnostou et al, 1990; Bussolino et al, 1991; Carlini et al, 1995) . In this work, we observed that G-CSF, GM-CSF, and EPO increased the number of capillary tubes by 65%, 41%, and 52% respectively. Moreover, addition of 0.1 ng/ml of SCF also increased the tube number by 27%. To our knowledge, an angiogenic role of SCF has not been reported yet, and might be specific for marrow microvascular cells. We must emphasize that the effect of SCF was observed for values as low as 0.1 ng/ml, and effects with increasing concentrations were not found. Moreover, SCF added to G-CSF, GM-CSF, or EPO was not found to be synergistic with the effects of these hematopoietic cytokines. These data underscore some of the major differences between the effect of SCF on endothelial cells in our culture system and its effect on hematopoietic colonies (Broudy, 1997) .
G-CSF and EPO were potent angiogenic factors in our culture conditions. G-CSF (100 ng/ml) and EPO (10 U/ml) induced a 100% increase in the number of tubes (versus a maximum increase of 78% using 0.1 ng/ml of VEGF, the optimal concentration for capillary tube increase). Marrow stromal cells are known to synthesize G-CSF, GM-CSF, EPO, and SCF (Bulabois et al, 1998; Sensebe, et al, 1997a; 1997b) . However, G-CSF synthesis is observed only after induction by inflammatory cytokines; EPO and SCF synthesis is variable from one layer to the other or when induced by IL-1; and GM-CSF release is minimal in the absence of IL-1. Therefore, it was not surprising to observe that neutralization of these cytokines did not modify the number of tubes, which suggests that stromal mesenchymal cells did not release substantial amounts of these growth factors under basal conditions.
In conclusion, this work describes capillary tube formation by human marrow microvascular endothelial cells in the presence of mesenchymal stromal cells and pericytes. In this model, VEGF seems to play a key role, in concert with the ␣ v ␤ 5 pathway and the production of NO. Pericytes involved in the maturation of tubes partially suppress the VEGF requirement for endothelial cells. The hematopoietic cytokines G-CSF, GM-CSF, and EPO are potent enhancers of tube formation. SCF also increases the number of tubes, an as yet undescribed function for this hematopoietic growth factor.
Materials and Methods
Endothelial Cell Isolation and Culture
Sternal bone marrow aspirates were obtained from patients undergoing cardiac surgery, after informed consent. The aspirates were collected in glass bottles containing heparin (100 I.U./bottle). Endothelial cells were isolated using a method derived from that described by Rafii et al (Rafii et al, 1994) .
Marrow aspirates were centrifuged. The fat supernatant was recovered using albumin-coated pipettes and digested by 0.1% collagenase (Type I collagenase, Sigma Chemical Company, St Louis, Missouri) for 1 hour at 37°C. The cells were then passaged through a 0.5 mm needle, washed once in phosphate buffered saline (PBS) and resuspended in 5 ml of RPMI (BioWhittaker-Europe, Verviers, Belgium) sup- plemented with 10% fetal bovine serum (FBS; GIBCO BRL, Gaithersburg, Missouri).
The selection of endothelial cells was performed using magnetic beads (M280 tosylactivated dynabeads, Dynal, Oslo, Norway) coated with Ulex europaeus agglutinin-1 (UEA-1; Vector Laboratories, Burlingame, California). Coating of the beads was performed by washing 6.7 ϫ 10 8 beads once in PBS, incubating at room temperature for 20 hours in 1 ml of PBS with 0.4 mg of UEA-1, washing twice in PBS, and resuspending in 2 ml of PBS. Beads were stored at 4°C until use.
Coated beads were added to the cell suspension (1.5 bead per cell), and the targeted cells were recovered using a magnetic particle concentrator (MPC, Dynal). Cells were then washed three times in PBS and resuspended in E-Stim medium (Becton Dickinson, Bedford, Massachusetts).
Selected cells were cultured in 25 cm 2 flasks (Becton Dickinson, Franklin Lakes, New Jersey) or on Lab Tek culture chamber slides (Eight-well permanox slides, Nunc, Illinois) coated with rat tail collagen type I (12 g/cm culture chamber slide. Cells were incubated at 37°C with 4% CO 2 . The cell layers were predominantly studied after the first passage, but could be used through five passages.
Immunofluorescence Studies
The culture medium was removed from Lab Tek culture chambers and the monolayer was washed once with PBS prior to fixation. Cells were either fixed with 3.7% (v/v) of formaldehyde in PBS for extracellular or plasma membrane labeling or permeabilized and fixed with cold methanol for intracellular labeling. In both cases, cells were fixed for 30 minutes at 4°C. Cells were then incubated for 30 minutes at room temperature with a primary antibody, washed twice in PBS, incubated for 30 minutes at room temperature with a secondary antibody, and washed twice in PBS. Controls were incubated with an irrelevant primary antibody. The source and concentration for primary and secondary antibodies are listed in Table 1 . Dilacetylated-low density lipoproteins (Paesel-Lorei, Hanau, Germany) were added to the culture medium two hours before cell analysis. An Aristoplan microscope (Leitz Wetzlar, Wetzlar, Germany) was used for observation.
Flow Cytometry Studies
After treatment with type I collagenase, cultured cells were recovered and washed twice in PBS. The labeling of cell suspensions was performed as described above for cells grown on Lab Tek chamber slides, according to concentrations indicated in Table 1 . The analysis was performed using a FACScan (Becton Dickinson) with Lysis II software (Becton Dickinson).
Functional Studies
Treatments of cultures were performed daily from approximately day 7 (75% confluence) to day 12. Substances were added as 1/100 of the culture medium volume in vehicle (PBS with 0.5% (w/v) bovine serum albumin (BSA, Sigma)). Controls contained vehicle only, irrelevant antibody of the same isotype, or non-immune serum for immunoneutralization assays. The effect was determined by comparing the number of endothelial tubes in treated and control wells after labeling with antibodies to von Willebrand Factor.
Electron Microscopy
Cultured layers were washed twice in PBS, fixed with 2% (v/v) glutaraldehyde in 0.1 M cacodylate buffer for 30 minutes at 4°C, and washed for 24 hours at 4°C with 0.2 M sucrose in 0.1 M cacodylate buffer. Postfixation was performed with 1% osmic acid in 0.15 M cacodylate buffer at 4°C for 15 minutes. Fixed preparations were dehydrated using a series of ethanol solutions from 70% to 100%. After embedding in Epoxy (Fluka, Buchs, Switzerland), sections were cut using a Super NOVA ultramicrotome (LKB, Stockholm, Sweden). The grids were observed with 1200 EX transmission electron microscope (JEOL, France) in the Ͻ Ͻ Centre commun de microscopie é lectronique Ͼ Ͼ at Besanç on.
Statistical Analysis
In the text, values are expressed as the mean Ϯ the standard error of the mean. Statistically significant differences between series were assessed by ANOVA using Statview software (Abacus Concepts, Berkeley, California).
